ライフサイエンスコーパス: marketing

1 game theory (auctions), and social networks (marketing).

2 nce through technological processes prior to marketing.

3 used to inform protected area management and marketing.

4 ay offer a partial view of exposed off-label marketing.

5 on physicians and traditional pharmaceutical marketing.

6 education, financial modeling, policing, and marketing.

7 pathways do not exist to guide research and marketing.

8 ssue for research, nutritional labelling and marketing.

9 rove living standards, and enhance livestock marketing.

10 as where ranking has a role, from science to marketing.

11 mbine several policy tools and strong social marketing.

12 d Drug Administration over its first year of marketing.

13 exponential growth driven mainly by creative marketing.

14 ulation of consumer and professional medical marketing.

15 tritional quality of EVOOs and improve their marketing.

16 s of policies that address affordability and marketing.

17 Pharmaceutical companies increased DTC marketing about diseases treated by their drugs with inc

18 employees relative to the Prescription Drug Marketing Act or the False Claims Act and probationary s

19 ty to one violation of the Prescription Drug Marketing Act, settled claims related to alleged violati

20 his study are relevant for understanding how marketing actions can affect consumer choice behavior as

21 e paper provides evidence for the ability of marketing actions to modulate neural correlates of exper

22 We propose that marketing actions, such as changes in the price of a pro

23 leblower complaints as involved in off-label marketing activities adequately disclosed their conflict

24 em was an important driving factor for these marketing activities, Medicare has shifted to an Average

25 ts in the US alleged multifaceted and covert marketing activities.

26 using community-based distributers as social marketing agents and incorporating financing systems to

27 Billions of dollars are spent annually marketing alcohol.

28 Despite the importance and pervasiveness of marketing, almost nothing is known about the neural mech

29 und 46 was halted due to the contemporaneous marketing and clinical withdrawal of other centrally act

30 evelopment, and creating efficiencies in the marketing and distribution of educational materials and

31 , we evaluated the effect of community-based marketing and distribution of Sprinkles MNP on childhood

32 ve proven immensely useful in fields such as marketing and earth sciences, public health is still rel

33 on, such as fear and distrust; and different marketing and education strategies.

34 on that upgraded the supply chain (combining marketing and home delivery), provided rebates and finan

35 osition, botanical aspects, pharmacological, marketing and nutrition of these species based on studie

36 iffusion in many applications, such as viral marketing and political campaigns.

37 lem are important for strategic decisions in marketing and political campaigns.

38 r advertisements; prohibiting youth-oriented marketing and sales; prohibiting child-friendly ENDS fla

39 ene therapy medicines have been licensed for marketing and several more are advancing toward that goa

40 Direct-to-consumer marketing and shared decision making reflect a culture w

41 mplicit positive associations with junk food marketing and substantially improves boys' daily dietary

42 ributed in part to the perception created by marketing and the popular press that they are safer than

43 clinical and regulatory decisions about the marketing and use of new treatments, these assumptions m

44 dissemination (education, communication, and marketing); and 7) accountability.

45 kage warning labels, restrict child-directed marketing, and ban sales in schools of all foods and bev

46 cognitive neuroscience, in the realm of law, marketing, and beyond.

47 tems engineering, organizational management, marketing, and health education were identified.

48 es in the areas of psychological assessment, marketing, and privacy.

49 cco products; regulation of the advertising, marketing, and promotion of tobacco products; regulation

50 access to resources for program development, marketing, and resource allocation.

51 an we parse out the effects of the labeling, marketing, and school sales ban policies.

52 d by the US Food and Drug Administration for marketing, and several others are in various stages of d

53 the dense built environment, pervasive food marketing, and the increased availability of energy-dens

54 cancer trials submitted as part of a drug's marketing application.

55 social science, social media analytics, and marketing applications.

56 nistration before Jan 1, 2019, in support of marketing applications.

57 n of failed applications is costly, delaying marketing approval and the availability of new drugs to

58 Finally, some important barriers to marketing approval are described.

59 ugs received US Food and Drug Administration marketing approval for acute myeloid leukemia (AML) trea

60 t thrombin inhibitor dabigatran has received marketing approval from the European Medicines Agency.

61 To overcome this, the FDA may grant marketing approval of a new product based upon the "Anim

62 rocesses that supported drug development and marketing approval of DAAs for treatment of hepatitis C,

63 gh-risk therapeutic devices received initial marketing approval via the PMA pathway.

64 ccess rates, with over 40% of INDs obtaining marketing approval, in a median time of about six years

65 f an anticancer agent at the time of initial marketing approval, sponsors customarily collect compreh

66 without industry champions to bring them to marketing approval, there may be justification for a mor

67 multiple sclerosis (MS) have recently gained marketing approval.

68 on and sale of these data for pharmaceutical marketing are currently the subjects of legislation in s

69 n intervention that frames manipulative food marketing as incompatible with important adolescent valu

70 cipants rated scenarios in which the use was marketing as less appropriate than when the use was rese

71 o establish a monopoly, it planned intensive marketing, as if in a competitive market, aiming to targ

72 afer or more effective new drugs and greater marketing associated with higher intraclass list prices.

73 ted approval pathways, including conditional marketing authorisation (CMA) and accelerated assessment

74 s of clinical investigation or have received marketing authorisation for adults; however, none have d

75 t need to be imposed by the regulator on the marketing authorisation holders.

76 A), speed up European Medicines Agency (EMA) marketing authorisation recommendations for medicinal pr

77 industry-oriented protocols before granting marketing authorisation.

78 The pivotal trial evidence supporting marketing authorisations for products granted CMA or AA

79 Marketing authorization by national authorities is neces

80 United States marketing authorization for one drug, gefitinib (an epid

81 umors, with (177)Lu-DOTATATE having acquired marketing authorization in Europe and the United States.

82 ucing country, then prequalified and given a marketing authorization in the user countries.

83 needed before considering a revision of the marketing authorization process for antibacterial generi

84 driving basic immunological research and for marketing authorization purposes by regulatory authoriti

85 nt phenolic antioxidant from rosemary with a marketing authorization, spontaneously forms a relativel

86 ffectiveness of interventions addressing the marketing, availability, and price of healthy and unheal

87 Policies focus on price, marketing, availability, information and education, the

88 iopolitical factors, such as tobacco-related marketing bans and higher cigarette taxes.

89 y illustrates the relative importance of the marketing based benefits that accrue to Leadership in En

90 riven by both performance-based benefits and marketing based benefits.

91 Marketing benefits due to LEED certification drives orga

92 Marketing benefits stem from the consumer response to gr

93 ipants in the LEED certification scheme seek marketing benefits.

94 oS displays will prevent this means of price marketing but our study also suggests that minimum prici

95 ed during the first two years of natalizumab marketing but, by the end of November, 2009, 28 cases ha

96 The FTC has acted against misleading marketing by a single for-profit cancer center.

97 Research and scholarship were also used for marketing by encouraging "key customers" to participate

98 eight loss centers or for direct-to-consumer marketing by manufacturers and does not apply to patient

99 concerns, and it has never been approved for marketing by the FDA.

100 pragmatic use and validation, we carry out a marketing campaign that shows a threefold increase in re

101 However, aggressive-marketing campaigns and lack of regulation of hospital w

102 t from the support of educational and social marketing campaigns developed with governmental input an

103 wer testimony have alleged complex off-label marketing campaigns that remain concealed to company out

104 bacco products, smoke-free policies, counter-marketing campaigns, advertising restrictions, augmentin

105 rs, as tobacco companies continue aggressive marketing campaigns.

106 Pharmaceutical marketing can lead to overdiagnosis, overtreatment, and

107 ry hurdles, which might prevent vendors from marketing cardiac MR perfusion imaging, may have hampere

108 ntify, document, and analyze U.S. businesses marketing "cell therapy" for ocular conditions as of Sep

109 ns of median price per ounce on the basis of marketing claims (eg, dermatologist recommended, fragran

110 However, an examination of Internet-based marketing claims revealed widespread promotion of such i

111 Pre-marketing clinical studies of tegaserod suggested an inc

112 ovement in the transparency of local seafood marketing compared to previous studies, the results rema

113 s that pass along research, development, and marketing costs to the consumer; providers of cancer car

114 ns of neuroscience to such diverse arenas as marketing, criminal justice, the military, and worker pr

115 acilitate the production of comparative post-marketing data by investing in the development of collab

116 division handled both the scientific and the marketing data, including collection, analysis, and diss

117 (InfoGroup, Papillion, Nebraska) commercial marketing database for neighborhood control recruitment

118 idential telephone numbers from a commercial marketing database.

119 le FDA violation letters for misleading drug marketing decreased from 156 to 11.

120 them in domains as diverse as epidemiology, marketing, development economics, and public health.

121 on to fulfill a marketing objective; Merck's marketing division handled both the scientific and the m

122 ey themes: The trial was designed by Merck's marketing division to fulfill a marketing objective; Mer

123 AGE was a seeding trial developed by Merck's marketing division to promote prescription of Vioxx (rof

124 he recent surge in direct-to-consumer device marketing, do-it-yourself enthusiasm, and an escalating

125 T patients, there is variability in the post-marketing dosing of regorafenib.

126 ent data sources can be used to augment post-marketing drug safety signal detection.

127 European Union law prohibits companies from marketing drugs off-label.

128 asible waste stream option and a sustainable marketing edge while treading the path toward a circular

129 For decades methodologists in psychology, marketing, education, and survey research have studied t

130 apers, documents were found describing Merck marketing employees developing plans for manuscripts, co

131 Schools present highly desirable marketing environments for food and beverage companies.

132 ve, randomized clinical trials and from post-marketing experience.

133 Adolescents are exposed to extensive marketing for junk food, which drives overconsumption by

134 ut the appropriateness of direct-to-consumer marketing for oncologic medications.

135 idence shows that ADVANTAGE is an example of marketing framed as science.

136 blower complaints alleging illegal off-label marketing from the US Department of Justice and other pu

137 d patients has been widespread, but how this marketing has contributed to the diffusion of the techno

138 edit, supply-chain strengthening, and social marketing have been ignored.

139 ed, participate in direct-to-consumer online marketing, have websites that can be data-mined with con

140 pain management, ethical lapses in corporate marketing, historical stigmas directed against people wh

141 d exposure to environmental cues (e.g., food marketing); however, the mechanisms that link these fact

142 e in the development, registration, and post-marketing implementation of new antibiotics.

143 ry and only two contained elements of social marketing in the design, although five addressed sustain

144 In 2001, alemtuzumab was approved for marketing in the United States and Europe for use in pat

145 ber of new antibiotics annually approved for marketing in the United States continues to decline.

146 ber of new antibiotics annually approved for marketing in the United States has reversed its previous

147 three rHuEPO products that are approved for marketing in the US or EU as biosimilars, and eight rHuE

148 ht rHuEPO products that are not approved for marketing in the US or EU.

149 Time from drug discovery to marketing increased from 8 years in 1960 to 12 to 15 yea

150 Medical marketing increased substantially from 1997 through 2016

151 ersight, taxation, flavorings, promotion and marketing, indoor and public use, and research.

152 cal acceptability of interactions; perceived marketing influence; perceived reliability of industry i

153 its collected and the use of recruitment and marketing initiatives that appeal to the increasingly di

154 Sponsors have a marketing interest to represent their products in the be

155 ntervention stores received a 6-mo, in-store marketing intervention that promoted the sales of health

156 or spending and number of ads); professional marketing (IQVIA Institute for Human Data Science, Open

157 gineering junk food to make it addictive and marketing it to young children.

158 However, the rapidly changing food-marketing landscape requires research to measure the eff

159 These include polling, marketing, management, insurance, and public health prog

160 on physician-industry interactions, industry marketing may target other health professionals.

161 ood policies are warranted to support social marketing messages and to reduce the cultural and econom

162 or reaching physicians, allowing delivery of marketing messages at the point of care, when clinical d

163 consumption trends consistent with industry marketing models would be expected to increase the impac

164 ), school-based programs (n = 2), and social marketing (n = 2) (2 interventions tested multiple appro

165 alysis, and dissemination; and Merck hid the marketing nature of the trial from participants, physici

166 d by Merck's marketing division to fulfill a marketing objective; Merck's marketing division handled

167 a scientific question but primarily fulfill marketing objectives, have not been described in detail.

168 artnership with industry will accelerate the marketing of a male hormonal contraceptive.

169 wn of the twentieth century, coincident with marketing of aspirin-a signature event in the history of

170 The marketing of breastmilk substitutes negatively affects b

171 rt has been expended to restrict the adverse marketing of breastmilk substitutes, similar effort now

172 However, successful marketing of complement-targeted drugs has proved to be

173 tensivists to remain in the field, proactive marketing of critical care, and expanded engagement by t

174 From 1997 through 2016, spending on medical marketing of drugs, disease awareness campaigns, health

175 pipe tobacco smoking has been abetted by the marketing of flavored tobacco, a social media environmen

176 tine method to avoid the mislabelling in the marketing of Genypterus species.

177 One alternative explanation is that the marketing of high-sugar foods, especially sugar-sweetene

178 fruit which often results in harvesting and marketing of inedible, immature or over ripe berries.

179 necessary to reduce exposure of children to marketing of less healthful foods.

180 ciated with the development, production, and marketing of new drugs and technologies, many of which a

181 f Spain) wants to promote the production and marketing of new sweet wines.

182 Galicia, wants to promote the production and marketing of new sweets wines.

183 are changing with increased availability and marketing of packaged and fast foods and sugar-sweetened

184 d inform the development, manufacturing, and marketing of pediatric medications for resource-limited

185 der children from increasingly sophisticated marketing of sedentary activities and energy-dense, nutr

186 ns, these findings suggest that labeling and marketing of some products which claim to provide these

187 eir availability in schools; restrictions on marketing of sugary foods to children; public awareness

188 tnership have challenged the development and marketing of telavancin.

189 h the Food and Drug Administration to permit marketing of the code.

190 atform, along with a manual search, from the marketing of the first PGA, latanoprost, in 1995 to the

191 rooms is an obstacle to the distribution and marketing of the fresh product.

192 were the major cause for discontinuation of marketing of these antibiotics.

193 of recommendations aimed at restricting the marketing of tobacco products.

194 g tobacco industry influence on taxation and marketing of tobacco; we included 45 of 46 papers in the

195 Direct-to-consumer marketing of unapproved stem cell interventions is a wel

196 oduce legislation to restrict the commercial marketing of unhealthy foods and beverages to children.W

197 odel to underpin regulations restricting the marketing of unhealthy foods to children.

198 excluded unless the testimonial appeared as marketing on a commercial site.

199 asure the effects of nontraditional forms of marketing on the health-related behaviors of children.

200 do not require clinical studies before their marketing or formal approval from regulatory agencies, a

201 that most medicines that were withdrawn from marketing or received a black-box warning because of hep

202 With improved functionality and marketing, outreach in the global south, and future tran

203 Despite the increase in marketing over 20 years, regulatory oversight remains li

204 e, and consequent ripening, which limits the marketing period in distant regions.

205 e evaluation of clinical benefit in the post-marketing period should be limited to instances when the

206 manufacturers to conduct studies in the post-marketing period, these studies might remain incomplete

207 of market approval often persist in the post-marketing period.

208 ers to generate comparative data in the post-marketing period.

209 (FAERS) remains the primary source for post-marketing pharmacovigilance.

210 resolved in a timely fashion during the post-marketing phase.

211 ted products but might be helpful from their marketing point-of-view.

212 PPD limits cassava's marketing possibilities in countries that are undergoing

213 nd state investigations of allegedly illegal marketing practices of other pharmaceutical firms and ha

214 iversity and/or government groups employ the marketing practices of pharmaceutical companies to impro

215 ct placement/choice architecture, innovative marketing practices, menu and product labeling, worksite

216 ng countries by teaching basic financial and marketing practices, yet the impacts of such programs ar

217 and may not represent a complete picture of marketing practices.

218 billion in fines for off-label or deceptive marketing practices.

219 ollect double red blood cell units; targeted marketing programs to provide effective messages; season

220 tine, and many ECIG manufacturers have begun marketing protonated nicotine products, often with high

221 are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19.

222 n based on the sales network, the price, the marketing quality and the presence of filters in the pac

223 ate on the implementation of sugar taxation, marketing regulation, and other sugar-related policies.

224 ure on tobacco industry efforts to influence marketing regulations and develops taxonomies of 1) indu

225 nce to tobacco industry efforts to influence marketing regulations; supported claims with verifiable

226 an injectable clinical biomaterial must meet marketing, regulatory, and financial constraints to prov

227 ng ultrasound contrast agents following post-marketing reports of 4 patient deaths that were temporal

228 (gift policies, r = 0.28, 95% CI 0.11-0.44; marketing representative access policies, r = 0.51, 95%

229 0.19-1.04) and less likely to interact with marketing representatives (AMSA score, OR 0.33, 95% CI 0

230 students' gift acceptance, interactions with marketing representatives, and perceived adequacy of fac

231 eceived gifts and having not interacted with marketing representatives.

232 lacement therapy (PERT) to have approval for marketing, rescinding the distribution of PERT that had

233 complexity, cost, and waste of rigorous post-marketing research efforts.

234 Often, post-marketing research landscape is fragmented.

235 ethods from operation risk index analysis in marketing research to develop a formula that considers a

236 overnment have instituted self-regulation of marketing, research in the psychology and social science

237 ere thus subject to the law's warning label, marketing restriction, and school sales ban policies.

238 een nutrient profile (NP) models relevant to marketing restrictions by applying them in the Canadian

239 mandated front-of-package warning labels and marketing restrictions for unhealthy foods and beverages

240 ncreases, 14% by smoke-free air laws, 14% by marketing restrictions, 8% by health warnings, 6% by mas

241 , smoke-free air laws, mass media campaigns, marketing restrictions, packaging requirements, cessatio

242 vary greatly between NP models applicable to marketing restrictions.

243 ss authorized the FDA to grant extensions of marketing rights known as "pediatric exclusivity" if FDA

244 tration (FDA) to grant 6-month extensions of marketing rights through the Pediatric Exclusivity Progr

245 are tasked with supervising compliance with marketing rules.

246 the production, shipment, storage, and post-marketing safety of generic oncology drugs.

247 tion are needed to prevent the inappropriate marketing, sale, and clinical use of unlicensed botulinu

248 e apparent strategic goals of each off-label marketing scheme and the practices consistent with those

249 e findings are consistent with the idea that marketing self-regulation has failed to keep television

250 on-level cohort study using Intercontinental Marketing Services Health Canada's data from June 2003 t

251 eloped world will need the manufacturing and marketing skills of the pharmaceutical industry.

252 ng their financial interests) such as social marketing, social franchising, vouchers, and contracting

253 ethylene pathway, and innovative storage and marketing solutions for current and novel fruit cultivar

254 is readily available via direct-to-consumer marketing strategies across the United States.

255 Marketing strategies and tactics were identified by usin

256 and using more sophisticated recruitment and marketing strategies as well as automated collection tec

257 research on this topic has mainly focused on marketing strategies for garnering public acceptance of

258 t is possible for programmes to adopt modern marketing strategies that are attractive to healthy clie

259 In-store marketing strategies that draw attention to healthier pr

260 veness of utilizing personalized direct-mail marketing strategies to promote organ donation with an e

261 Few controlled studies of in-store marketing strategies to promote sales of healthier items

262 tudy was to evaluate the effects of in-store marketing strategies to promote the purchase of specific

263 -the present campaign employed a direct-mail marketing strategy that registered 6908 individuals in t

264 Even when completed, many post-marketing studies lack meaningful active comparators, ha

265 Second, post-marketing studies should be designed hierarchically: pri

266 Third, post-marketing studies should incorporate active comparators

267 ing With Emboli Protection Surveillance-Post-Marketing Study [CASES-PMS]; NCT00231231).

268 ing With Emboli Protection Surveillance-Post-Marketing Study) multicenter, prospective, single-arm, s

269 ve measurement of adoption to inform design, marketing, subsidies, finance, or dissemination practice

270 pproach that utilizes clinical SEs from post-marketing surveillance and the drug label to predict 1,5

271 rug reactions warrants an evaluation of post marketing surveillance data.

272 EGF agents will only be achieved though post-marketing surveillance or through the interrogation of h

273 The objective of the Olestra Post-Marketing Surveillance Study was to examine whether cust

274 In a non-interventional, observational, post-marketing surveillance study, patients with an establish

275 ed with trends on clinical outcomes and post-marketing surveillance to assess safety, serve as the fo

276 ents in the ongoing outcome studies and post-marketing surveillance.

277 Changes to these device approval and post-marketing systems must be accompanied by ongoing researc

278 s have FCOIs with the pharmaceutical company marketing that drug.

279 bacco control policies should prohibit price marketing that otherwise erodes the full impact of such

280 dronic acid received regulatory approval for marketing, the FDA received reports of nine patients wit

281 Although these initiatives need improved marketing, the Society of Critical Care Medicine members

282 st half of prepackaged foods as eligible for marketing to children [49.0% (95% CI: 48.2%, 49.8%)].

283 oportion of foods that would be eligible for marketing to children was calculated with the use of eac

284 Marketing to health care professionals by pharmaceutical

285 Pharmaceutical marketing to health professionals accounted for most spe

286 s can be learned and principles applied from marketing to highlight the potential pitfalls of current

287 ood companies' stated intentions to increase marketing to Hispanics.

288 Marketing to physicians, hospitals, and patients has bee

289 ears, despite the industry's intent to avoid marketing to underage persons.

290 communities in rural Bangladesh to different marketing treatments-community motivation and informatio

291 ician practitioners working for US companies marketing unproven stem cell procedures.

292 es, and caution about unscrupulous 'clinics' marketing unproven therapies to patients.

293 Mean ratings ranged from a low of 3.81 for a marketing use when consent was not obtained and specific

294 ere rated as more appropriate than consented marketing uses (5.65 vs. 4.52; difference, 1.13 [CI, 0.8

295 flour with higher phenolics may have greater marketing value in the future.

296 The UK self-regulatory system for exposing marketing violations relies largely on complaints from c

297 Social marketing was used to create awareness and generate dema

298 d and a pharmaceutical company used data for marketing (weighted mean appropriateness, 2.7).

299 Combining social marketing with community-based distribution provides an

300 th Food and Drug Administration approval for marketing - Y(90) ibritumomab tiuxetan and I(131) tositu